TWIST1 and prostate carcinoma: Furthermore, miR-145-5p interacts with lnc-ZNF30-3 in prostate cancer through a ceRNA mechanism: lnc-ZNF30-3 acts as a molecular sponge, sequestering miR-145-5p and negating its inhibitory effects on TWIST1 and other EMT-associated transcription factors.